Boehringer Ingelheim
Boehringer Ingelheim is a global pharmaceutical company headquartered in Ingelheim am Rhein, Germany. Founded in 1885 by Albert Boehringer, the company has grown to become one of the world's leading research-driven pharmaceutical enterprises.
History[edit | edit source]
The company was established by Albert Boehringer in 1885 in the small town of Ingelheim am Rhein. Initially, the company focused on the production of tartaric acid salts, which were used in the food industry. In 1893, Boehringer discovered that lactic acid could be produced in large quantities through bacterial fermentation, marking a significant milestone in the company's history.
In 1917, Boehringer Ingelheim patented its first pharmaceutical product, a baking powder called Boeson. This marked the company's entry into the pharmaceutical industry.
Research and Development[edit | edit source]
Boehringer Ingelheim is renowned for its commitment to research and development (R&D). The company invests a significant portion of its revenue into R&D, focusing on areas such as respiratory diseases, cardiometabolic diseases, oncology, and diseases of the central nervous system.
Global Presence[edit | edit source]
Boehringer Ingelheim operates globally, with a presence in over 100 countries. The company employs more than 50,000 people worldwide and has a strong commitment to improving human and animal health.
Products[edit | edit source]
The company's product portfolio includes prescription medicines, consumer health care products, and animal health products. Some of its well-known products include Spiriva, Pradaxa, and NexGard.
Corporate Social Responsibility[edit | edit source]
Boehringer Ingelheim is committed to corporate social responsibility, focusing on sustainable development, environmental protection, and social engagement. The company supports various initiatives aimed at improving health care access and education in underserved communities.
Headquarters[edit | edit source]
The company's headquarters are located in Ingelheim am Rhein, Germany. The site includes state-of-the-art research facilities and serves as the central hub for the company's global operations.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
